ANALYSIS OF RISK FACTORS IN THE TREATMENT AND PREVENTION OF PNEUMONIA

Pneumonia is an acute infectious inflammation of the lung parenchyma, primarily affecting the alveoli. It remains a widespread disease and a significant contributor to global mortality. According to the World Health Organization (WHO), pneumonia accounts for approximately 14% of deaths among children under five years of age [2]. Timely initiation of appropriate treatment is crucial for preventing severe disease progression and associated complications [1].